Germany - Conclusion of a non-exclusive discount agreement in accordance with Section 130a Paragraph 8 SGB V for drugs with the active ingredient tocilizumab (ATC code: L04AC07).

World Biggest Tenders Source

This tender with title Germany - Conclusion of a non-exclusive discount agreement in accordance with Section 130a Paragraph 8 SGB V for drugs with the active ingredient tocilizumab (ATC code: L04AC07). has been published on Bidding Source portal dated 25 Sep 2023 for the country of Germany. It has been categorized on Immunosuppressive agents. For similar tenders you can see tenders mentioned below of this page.

General Information

Germany

Tender Title :

Germany - Conclusion of a non-exclusive discount agreement in accordance with Section 130a Paragraph 8 SGB V for drugs with the active ingredient tocilizumab (ATC code: L04AC07).

Tender Type :

Invitation for Bids

Country :

Germany

Province/City :

Germany-Hanover

Publish Date :

25 Sep 2023

Closing Date :

27 Aug 2025

Notice Language :

English

Tender Categories (CPVs) :

Immunosuppressive agents

Full Tender Details :

For viewing full details of tenders, you should Log in to your account. If not registered yet, Please Register Now

Or Request a call back now and one of our representatives will contact you. Contact us

Similar Tenders

Conclusion of a non-exclusive discount agreement in accordance with Section 130a Paragraph 8 SGB V for drugs with the active ingredient abatacept (ATC code: L04AA24). Germany Germany - Conclusion of a non-exclusive discount agreement in accordance with Section 130a Paragraph 8 SGB V for drugs with the active ingredient certolizumab pegol (ATC code: L04AB05). Germany Germany - Automation of immunosuppressants in the LC MS/MS process Germany Abschluss eines nicht exklusiven Rabattvertrages nach § 130a Abs. 8 SGB V zu Arzneimitteln mit dem Wirkstoff Fingolimod (ATC-Code: L04AA27). -- <h6>Conclusion of a non-exclusive discount agreement according to Section 130a Paragraph 8 SGB V for medicinal products with the active ingredient fingolimod (ATC code: L04AA27).</h6> Germany Conclusion of a non-exclusive discount agreement in accordance with § 130a Paragraph 8 SGB V for drugs with the active ingredient infliximab (ATC code: L04AB02). Germany Abschluss eines nicht exklusiven Rabattvertrages nach § 130a Abs. 8 SGB V zu Arzneimitteln mit dem Wirkstoff Teriflunomid (ATC-Code: L04AA31). -- Immunosuppressive agents Germany Abschluss eines nicht exklusiven Rabattvertrages nach § 130a Abs. 8 SGB V zu Arzneimitteln mit dem Wirkstoff Tacrolimus (ATC-Code: L04AD02) -- Immunosuppressive agents Germany Abschluss eines nicht exklusiven Rabattvertrages nach § 130a Abs. 8 SGB V zu Arzneimitteln mit dem Wirkstoff Etanercept (ATC-Code: L04AB01) -- Immunosuppressive agents Germany Abschluss eines nicht exklusiven Rabattvertrages nach § 130a Abs. 8 SGB V zu Arzneimitteln mit dem Wirkstoff Infliximab (ATC-Code: L04AB02) -- Immunosuppressive agents Germany Abschluss eines nicht exklusiven Rabattvertrages nach § 130a Abs. 8 SGB V zu Arzneimitteln mit dem Wirkstoff Tacrolimus (ATC-Code: L04AD02) -- Immunosuppressive agents Germany

Germany - Conclusion of a non-exclusive discount agreement in accordance with Section 130a Paragraph 8 SGB V for drugs with the active ingredient tocilizumab (ATC code: L04AC07).

General Information

Germany

Similar Tenders

Immunosuppressive agents Tenders

Germany Tenders

Europe Tenders

Tenders

info@biddingsource.com